BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 31070479)

  • 1. Liquid Biopsy of Extracellular Microvesicles Predicts Future Major Ischemic Events in Genetically Characterized Familial Hypercholesterolemia Patients.
    Suades R; Padró T; Crespo J; Sionis A; Alonso R; Mata P; Badimon L
    Arterioscler Thromb Vasc Biol; 2019 Jun; 39(6):1172-1181. PubMed ID: 31070479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High miR-133a levels in the circulation anticipates presentation of clinical events in familial hypercholesterolaemia patients.
    Escate R; Padró T; Suades R; Camino S; Muñiz O; Diaz-Diaz JL; Sionis A; Mata P; Badimon L
    Cardiovasc Res; 2021 Jan; 117(1):109-122. PubMed ID: 32061123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liquid Biopsy of Extracellular Microvesicles Maps Coronary Calcification and Atherosclerotic Plaque in Asymptomatic Patients With Familial Hypercholesterolemia.
    Chiva-Blanch G; Padró T; Alonso R; Crespo J; Perez de Isla L; Mata P; Badimon L
    Arterioscler Thromb Vasc Biol; 2019 May; 39(5):945-955. PubMed ID: 30866660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD142+/CD61+, CD146+ and CD45+ microparticles predict cardiovascular events in high risk patients following a Mediterranean diet supplemented with nuts.
    Chiva-Blanch G; Crespo J; Suades R; Arderiu G; Padro T; Vilahur G; Cubedo J; Corella D; Salas-Salvadó J; Arós F; Martínez-González MA; Ros E; Fitó M; Estruch R; Badimon L
    Thromb Haemost; 2016 Jul; 116(1):103-14. PubMed ID: 27052787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High levels of TSP1+/CD142+ platelet-derived microparticles characterise young patients with high cardiovascular risk and subclinical atherosclerosis.
    Suades R; Padró T; Alonso R; Mata P; Badimon L
    Thromb Haemost; 2015 Nov; 114(6):1310-21. PubMed ID: 26178021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial Hypercholesterolemia-Risk-Score: A New Score Predicting Cardiovascular Events and Cardiovascular Mortality in Familial Hypercholesterolemia.
    Paquette M; Bernard S; Cariou B; Hegele RA; Genest J; Trinder M; Brunham LR; Béliard S; Baass A
    Arterioscler Thromb Vasc Biol; 2021 Oct; 41(10):2632-2640. PubMed ID: 34433300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating CD45+/CD3+ lymphocyte-derived microparticles map lipid-rich atherosclerotic plaques in familial hypercholesterolaemia patients.
    Suades R; Padró T; Alonso R; López-Miranda J; Mata P; Badimon L
    Thromb Haemost; 2014 Jan; 111(1):111-21. PubMed ID: 24085382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronary Heart Disease, Peripheral Arterial Disease, and Stroke in Familial Hypercholesterolaemia: Insights From the SAFEHEART Registry (Spanish Familial Hypercholesterolaemia Cohort Study).
    Pérez de Isla L; Alonso R; Mata N; Saltijeral A; Muñiz O; Rubio-Marin P; Diaz-Diaz JL; Fuentes F; de Andrés R; Zambón D; Galiana J; Piedecausa M; Aguado R; Mosquera D; Vidal JI; Ruiz E; Manjón L; Mauri M; Padró T; Miramontes JP; Mata P;
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):2004-10. PubMed ID: 27444203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutational analysis and genotype-phenotype relation in familial hypercholesterolemia: The SAFEHEART registry.
    Bourbon M; Alves AC; Alonso R; Mata N; Aguiar P; Padró T; Mata P
    Atherosclerosis; 2017 Jul; 262():8-13. PubMed ID: 28475941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ApoL1 levels in high density lipoprotein and cardiovascular event presentation in patients with familial hypercholesterolemia.
    Cubedo J; Padró T; Alonso R; Mata P; Badimon L
    J Lipid Res; 2016 Jun; 57(6):1059-73. PubMed ID: 27112635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of platelet-derived microvesicles and their phenotypes with carotid atherosclerosis and recurrent vascular events in patients after ischemic stroke.
    Rosińska J; Ambrosius W; Maciejewska J; Narożny R; Kozubski W; Łukasik M
    Thromb Res; 2019 Apr; 176():18-26. PubMed ID: 30763823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting Cardiovascular Events in Familial Hypercholesterolemia: The SAFEHEART Registry (Spanish Familial Hypercholesterolemia Cohort Study).
    Pérez de Isla L; Alonso R; Mata N; Fernández-Pérez C; Muñiz O; Díaz-Díaz JL; Saltijeral A; Fuentes-Jiménez F; de Andrés R; Zambón D; Piedecausa M; Cepeda JM; Mauri M; Galiana J; Brea Á; Sanchez Muñoz-Torrero JF; Padró T; Argueso R; Miramontes-González JP; Badimón L; Santos RD; Watts GF; Mata P
    Circulation; 2017 May; 135(22):2133-2144. PubMed ID: 28275165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of premature familial arterial thrombosis in patients with juvenile ischaemic stroke. The Italian Project on Stroke in Young Adults (IPSYS).
    Pezzini A; Grassi M; Lodigiani C; Patella R; Gandolfo C; Zini A; DeLodovici ML; Paciaroni M; Del Sette M; Toriello A; Musolino R; Calabrò RS; Bovi P; Adami A; Silvestrelli G; Sessa M; Cavallini A; Marcheselli S; Bonifati DM; Checcarelli N; Tancredi L; Chiti A; Del Zotto E; Spalloni A; Costa P; Giacalone G; Ferrazzi P; Poli L; Morotti A; Rasura M; Simone AM; Gamba M; Cerrato P; Micieli G; Melis M; Massucco D; De Giuli V; Pepe D; Iacoviello L; Padovani A;
    Thromb Haemost; 2015 Mar; 113(3):641-8. PubMed ID: 25413729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Annexin V
    Bratseth V; Margeirsdottir HD; Chiva-Blanch G; Heier M; Solheim S; Arnesen H; Dahl-Jørgensen K; Seljeflot I
    J Diabetes Res; 2020; 2020():7216863. PubMed ID: 32309448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of Measuring Lipoprotein(a) During Cascade Testing for Familial Hypercholesterolemia.
    Ellis KL; Pérez de Isla L; Alonso R; Fuentes F; Watts GF; Mata P
    J Am Coll Cardiol; 2019 Mar; 73(9):1029-1039. PubMed ID: 30846097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DIAgnosis and Management Of familial hypercholesterolemia in a Nationwide Design (DIAMOND-FH): Prevalence in Switzerland, clinical characteristics and the diagnostic value of clinical scores.
    Miserez AR; Martin FJ; Spirk D
    Atherosclerosis; 2018 Oct; 277():282-288. PubMed ID: 30270060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Universal screening for familial hypercholesterolemia in children: The Slovenian model and literature review.
    Groselj U; Kovac J; Sustar U; Mlinaric M; Fras Z; Podkrajsek KT; Battelino T
    Atherosclerosis; 2018 Oct; 277():383-391. PubMed ID: 30270075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Term Cardiovascular Risk in Heterozygous Familial Hypercholesterolemia Relatives Identified by Cascade Screening.
    Kjærgaard KA; Christiansen MK; Schmidt M; Olsen MS; Jensen HK
    J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28652386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health related quality of life in individuals at high risk for familial hypercholesterolemia undergoing genetic cascade screening in Brazil.
    Souto AC; Miname MH; Fukushima J; Jannes CE; Krieger JE; Hagger M; Pereira AC; Santos RD
    Atherosclerosis; 2018 Oct; 277():464-469. PubMed ID: 30270086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detecting familial hypercholesterolemia by serum lipid profile screening in a hospital setting: Clinical, genetic and atherosclerotic burden profile.
    Scicali R; Di Pino A; Platania R; Purrazzo G; Ferrara V; Giannone A; Urbano F; Filippello A; Rapisarda V; Farruggia E; Piro S; Rabuazzo AM; Purrello F
    Nutr Metab Cardiovasc Dis; 2018 Jan; 28(1):35-43. PubMed ID: 28958694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.